Home > Balance Sheet > BAL PHARMA

BAL PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
AD     Remove this Ad

BAL PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹-0.41 Cr₹1.55 Cr₹0.70 Cr₹0.60 Cr₹2.63 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of BAL PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of BAL PHARMA is ₹-0.41 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹-0.41 Cr
Mar2024₹1.55 Cr
Mar2023₹0.70 Cr
Mar2022₹0.60 Cr
Mar2021₹2.63 Cr

How is Deferred Tax Assets / Liabilities of BAL PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹-0.41 Cr
Negative
Mar2024 ₹1.55 Cr
120.34
Mar2023 ₹0.70 Cr
16.39
Mar2022 ₹0.60 Cr
-77.05
Mar2021 ₹2.63 Cr -

Compare Deferred Tax Assets / Liabilities of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹116.5 Cr 4.6% 0.7% -38.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,698.0 Cr 0.2% -1.3% -3.5% Stock Analytics
DIVIS LABORATORIES ₹163,866.0 Cr 1.9% -6.7% 0.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,062.0 Cr 1.3% 2.9% 28.7% Stock Analytics
CIPLA ₹108,412.0 Cr 1.3% -8.5% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹104,805.0 Cr 1.3% 3.8% 4.5% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

4.6%

0.7%

-38.1%

SENSEX

0.6%

0.1%

9.2%


You may also like the below Video Courses